Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.09.16.613338

Synaptic Specializations at Dopamine Release Sites Orchestrate Efficient and Precise Neuromodulatory Signaling

Abstract

Neuromodulators are generally understood to act through expansive projections that broadcast signals relatively indiscriminately, in stark contrast to the precise, synapse-bound organization of fast neurotransmitters like glutamate and GABA. This dichotomy has left the local architecture of neuromodulatory release and receptor engagement largely obscure. Here, using dopamine as a model system, we reveal that neuromodulatory signaling can be guided by precise molecular specificity. We show that dopamine axons exhibit a fundamental tropism for neurons expressing D1 or D2 receptors in the striatum and amygdala, a targeting principle that is conserved in dissociated co-cultures. Importantly, single-bouton-resolved optical imaging of release shows that dopamine is not broadcast broadly but is highly localized to varicosities that form direct, synapse-like appositions with receptor-expressing somata and dendrites. In contrast, varicosities lacking such appositions, or contacting receptor-negative neurons, are largely quiescent, indicating that local interactions with receptor-expressing targets help specify dopamine release competence. To directly visualize receptor organization relative to release sites at endogenous expression levels, we generated ALFA-tag knock-in mice (ALFADoR mice) in which the N-termini of D1 and D2 dopamine receptors are epitope-tagged. Combining these mice with immunolabeling and expansion microscopy in dissociated culture and intact tissue, we show that both D1 and D2 receptors are organized into discrete puncta rather than diffuse membrane distributions. Across major terminal fields of midbrain dopamine neurons, including striatum, amygdala, and prefrontal cortex, these receptor nanoclusters are preferentially positioned near dopamine varicosities at distances far smaller than expected from spatial shuffling controls. Moreover, receptor clusters apposed to dopamine varicosities were observed to be larger than non-apposed clusters, consistent with specialized receptor microdomains that may enhance signaling efficacy. Together, our data demonstrate that dopaminergic signaling is spatially organized by receptor-specific targeting and subcellular microdomain specialization. This structured framework challenges the canonical dichotomy between precise fast transmission and diffuse neuromodulation. It reveals that principles of synaptic organization extend to and define a previously hidden layer of specificity in neuromodulatory systems, opening new frontiers in understanding cell-type specific neuromodulation, axon guidance, and subcellular GPCR organization.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bulumulla, C., Walpita, D., Iyer, N., Eddison, M., Patel, R., Alcor, D., Ackerman, D., Beyene, A. G.. 2024-09-16. Synaptic Specializations at Dopamine Release Sites Orchestrate Efficient and Precise Neuromodulatory Signaling. https://doi.org/10.1101/2024.09.16.613338

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗